{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000009", "version": 4, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2001-06-01"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Tournamille et al. (1998) and Olsson et al. (1998) described a Duffy allele, FYB-weak (FYB-WK), or FYX, in approximately 3.5% of the population that, because of an arg89-to-cys (R89C) substitution in the first cytoplasmic domain of DARC, results in reduced levels of protein, lower antigen expression, and reduced ability to bind chemokines. The phenotype is called Fy(bwk), Fy(x), or either Fy(a-b+(weak)) or Fy(a+b+(weak)). The R89C substitution results from a C-to-T change at nucleotide 286 of the DARC gene."}, "citations": [{"ids": [{"source": "PubMed", "value": "9731074"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "9886340"}], "type": "general"}]}, {"attribute": {"type": "Description", "value": "Parasol et al. (1998) noted that, in addition to West African blacks, the Duffy-null phenotype also occurs in non-Ashkenazi Jews, being found, for example, in approximately 20% of Jews from Yemen. They found that in some of these cases Fy(b-) individuals had the wildtype FY*B GATA but carried 271C-T and 304G-A mutations. The 271C-T substitution resulted in an R91C amino acid substitution (R89C in the predominant DARC isoform reported by Iwamoto et al. (1996)), which represented a considerable change of chemical nature, one that may affect the antigenic determinants of DARC, and thus may be of clinical significance. Parasol et al. (1998) noted that further studies were needed to determine whether erythrocytes carrying these mutations behave as Fy(bwk) variants."}, "citations": [{"ids": [{"source": "PubMed", "value": "8547665"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "9746760"}], "type": "general"}]}, {"attribute": {"type": "Description", "value": "Carrington et al. (1997) described a CCR5 (601373) allele that carries a single amino acid substitution (R60S; 601373.0008) in the first intracellular domain of the protein that in heterozygous state appears to protect against human immunodeficiency virus (HIV) infection (see 609423). Tamasauskas et al. (2001) showed that in both the CCR5 R60S and DARC R89C alleles, the loss of a positive charge from the intracellular loop leads to reduced surface expression, thereby identifying a novel mechanism that may be protective against disease: against malarial infection by Plasmodium vivax in the case of the DARC gene and against AIDS in the case of the CCR5 gene."}, "citations": [{"ids": [{"source": "PubMed", "value": "11369664"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "9399903"}], "type": "general"}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000018396", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_002036.4(ACKR1):c.265C>T (p.Arg89Cys)"}}], "canonical_spdi": "NC_000001.11:159205703:C:T", "attributes": [{"type": "HGVS, coding, LRG", "value": "LRG_801t1:c.265C>T"}, {"type": "HGVS, coding, RefSeq", "value": "NM_002036.4:c.265C>T"}, {"type": "HGVS, coding, RefSeq", "value": "NM_001122951.3:c.271C>T"}, {"type": "HGVS, genomic, LRG", "value": "LRG_801:g.6692C>T"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_011626.3:g.6692C>T"}, {"type": "HGVS, genomic, top level", "value": "NC_000001.11:g.159205704C>T"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000001.10:g.159175494C>T"}, {"type": "HGVS, protein"}, {"type": "HGVS, protein", "value": "LRG_801p1:p.Arg89Cys"}, {"type": "HGVS, protein", "value": "Q16570:p.Arg89Cys"}, {"type": "HGVS, protein, RefSeq", "value": "NP_002027.2:p.Arg89Cys"}, {"type": "HGVS, protein, RefSeq", "value": "NP_001116423.1:p.Arg91Cys"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_001122951.3:c.271C>T"}]}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_002036.4:c.265C>T"}]}, {"type": "ProteinChange1LetterCode", "value": "R89C"}, {"type": "ProteinChange1LetterCode", "value": "R91C"}, {"type": "ProteinChange3LetterCode", "value": "ARG89CYS"}], "global_minor_allele_frequency": {"value": 0.00459, "source": "1000 Genomes Project", "minor_allele": "T"}, "sequence_location": [{"assembly": "GRCh38", "chr": "1", "accession": "NC_000001.11", "start": 159205704, "stop": 159205704, "display_start": 159205704, "display_stop": 159205704, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 159205704, "reference_allele_vcf": "C", "alternate_allele_vcf": "T"}, {"assembly": "GRCh37", "chr": "1", "accession": "NC_000001.10", "start": 159175494, "stop": 159175494, "display_start": 159175494, "display_stop": 159175494, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 159175494, "reference_allele_vcf": "C", "alternate_allele_vcf": "T"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "atypical chemokine receptor 1 (Duffy blood group)"}}], "symbols": [{"value": {"type": "Preferred", "value": "ACKR1"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "1", "accession": "NC_000001.11", "start": 159204875, "stop": 159206500, "display_start": 159204875, "display_stop": 159206500, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "1", "accession": "NC_000001.10", "start": 159173802, "stop": 159176289, "display_start": 159173802, "display_stop": 159176289, "strand": "+", "variant_length": 2488, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "2532"}, {"db": "OMIM", "id": "613665", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:4035"}]}], "xrefs": [{"db": "UniProtKB", "id": "Q16570#VAR_015068"}, {"db": "OMIM", "id": "613665.0003", "type": "Allelic variant"}, {"db": "dbSNP", "id": "34599082", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_002036.4(ACKR1):c.265C>T (p.Arg89Cys)"}}], "xrefs": [{"db": "ClinGen", "id": "CA113789"}], "id": 18396}, "trait_set": {"type": "Disease", "traits": [{"type": "BloodGroup", "names": [{"value": {"type": "Preferred", "value": "DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE"}, "xrefs": [{"db": "OMIM", "id": "613665.0003", "type": "Allelic variant"}]}]}], "id": 6213}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57512}, "record_status": "current", "title": "NM_002036.4(ACKR1):c.265C>T (p.Arg89Cys) AND DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE", "clinvar_assertions": [{"id": 20152, "clinvar_submission_id": {"local_key": "613665.0003_DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE", "submitter": "OMIM", "title": "ACKR1, ARG89CYS_DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE", "submitter_date": "2017-12-11"}, "clinvar_accession": {"acc": "SCV000020152", "version": 3, "type": "SCV", "date_updated": "2017-12-15", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2001-06-01"}], "external_ids": [{"db": "OMIM", "id": "613665.0003", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Tournamille et al. (1998) and Olsson et al. (1998) described a Duffy allele, FYB-weak (FYB-WK), or FYX, in approximately 3.5% of the population that, because of an arg89-to-cys (R89C) substitution in the first cytoplasmic domain of DARC, results in reduced levels of protein, lower antigen expression, and reduced ability to bind chemokines. The phenotype is called Fy(bwk), Fy(x), or either Fy(a-b+(weak)) or Fy(a+b+(weak)). The R89C substitution results from a C-to-T change at nucleotide 286 of the DARC gene."}, "citations": [{"ids": [{"source": "PubMed", "value": "9731074"}]}, {"ids": [{"source": "PubMed", "value": "9886340"}]}]}, {"attribute": {"type": "Description", "value": "Parasol et al. (1998) noted that, in addition to West African blacks, the Duffy-null phenotype also occurs in non-Ashkenazi Jews, being found, for example, in approximately 20% of Jews from Yemen. They found that in some of these cases Fy(b-) individuals had the wildtype FY*B GATA but carried 271C-T and 304G-A mutations. The 271C-T substitution resulted in an R91C amino acid substitution (R89C in the predominant DARC isoform reported by Iwamoto et al. (1996)), which represented a considerable change of chemical nature, one that may affect the antigenic determinants of DARC, and thus may be of clinical significance. Parasol et al. (1998) noted that further studies were needed to determine whether erythrocytes carrying these mutations behave as Fy(bwk) variants."}, "citations": [{"ids": [{"source": "PubMed", "value": "9746760"}]}, {"ids": [{"source": "PubMed", "value": "8547665"}]}]}, {"attribute": {"type": "Description", "value": "Carrington et al. (1997) described a CCR5 (601373) allele that carries a single amino acid substitution (R60S; 601373.0008) in the first intracellular domain of the protein that in heterozygous state appears to protect against human immunodeficiency virus (HIV) infection (see 609423). Tamasauskas et al. (2001) showed that in both the CCR5 R60S and DARC R89C alleles, the loss of a positive charge from the intracellular loop leads to reduced surface expression, thereby identifying a novel mechanism that may be protective against disease: against malarial infection by Plasmodium vivax in the case of the DARC gene and against AIDS in the case of the CCR5 gene."}, "citations": [{"ids": [{"source": "PubMed", "value": "9399903"}]}, {"ids": [{"source": "PubMed", "value": "11369664"}]}], "xrefs": [{"db": "OMIM", "id": "601373", "type": "MIM"}, {"db": "OMIM", "id": "609423", "type": "MIM"}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "ACKR1, ARG89CYS"}}], "attributes": [{"type": "NonHGVS", "value": "ARG89CYS"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "ACKR1"}}]}], "xrefs": [{"db": "OMIM", "id": "613665.0003", "type": "Allelic variant"}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000297", "version": 2, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2009-09-01"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Salipante et al. (2009) analyzed the KLHDC8B gene in 52 probands from families with 2 or more individuals with classic Hodgkin lymphoma (236000) and identified a +28C-T transition at a highly conserved nucleotide in the 5-prime UTR that was present in probands from 3 (5.8%) of 52 families compared with 4 (1.3%) of 307 controls (odds ratio, 4.64; 95% confidence interval, 1.01-21.4). The variant segregated with disease, and individuals heterozygous for the T allele were found to produce lower levels of KLHDC8B than those homozygous for the more common C allele. Studies in transfected HeLA cells demonstrated an approximately 50% reduction in translation of mRNA with the T allele compared to the C allele."}, "citations": [{"ids": [{"source": "PubMed", "value": "19706467"}], "type": "general"}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000000273", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_173546.3(KLHDC8B):c.-158C>T"}}, {"value": {"type": "Alternate", "value": "KLHDC8B, 5-PRIME UTR, +28C-T"}, "xrefs": [{"db": "OMIM", "id": "613169.0001", "type": "Allelic variant"}]}], "canonical_spdi": "NC_000003.12:49171661:C:T", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_173546.3:c.-158C>T"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_027702.1:g.5078C>T"}, {"type": "HGVS, genomic, top level", "value": "NC_000003.12:g.49171662C>T"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000003.11:g.49209095C>T"}, {"type": "HGVS, previous", "value": "NM_173546.2:c.-158C>T"}, {"type": "MolecularConsequence", "value": "5 prime UTR variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001623"}, {"db": "RefSeq", "id": "NM_173546.3:c.-158C>T"}]}], "global_minor_allele_frequency": {"value": 0.003, "source": "1000 Genomes Project", "minor_allele": "T"}, "sequence_location": [{"assembly": "GRCh38", "chr": "3", "accession": "NC_000003.12", "start": 49171662, "stop": 49171662, "display_start": 49171662, "display_stop": 49171662, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 49171662, "reference_allele_vcf": "C", "alternate_allele_vcf": "T"}, {"assembly": "GRCh37", "chr": "3", "accession": "NC_000003.11", "start": 49209095, "stop": 49209095, "display_start": 49209095, "display_stop": 49209095, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 49209095, "reference_allele_vcf": "C", "alternate_allele_vcf": "T"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "kelch domain containing 8B"}}], "symbols": [{"value": {"type": "Preferred", "value": "KLHDC8B"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "3", "accession": "NC_000003.12", "start": 49171598, "stop": 49176486, "display_start": 49171598, "display_stop": 49176486, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "3", "accession": "NC_000003.11", "start": 49209017, "stop": 49213918, "display_start": 49209017, "display_stop": 49213918, "strand": "+", "variant_length": 4902, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "200942"}, {"db": "OMIM", "id": "613169", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:28557"}]}], "xrefs": [{"db": "OMIM", "id": "613169.0001", "type": "Allelic variant"}, {"db": "dbSNP", "id": "387906223", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_173546.3(KLHDC8B):c.-158C>T"}}], "xrefs": [{"db": "ClinGen", "id": "CA114098"}], "id": 273}, "trait_set": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Classic Hodgkin lymphoma"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0009348"}]}, {"value": {"type": "Alternate", "value": "Hodgkin lymphoma"}, "xrefs": [{"db": "Genetic Alliance", "id": "Hodgkin+lymphoma/3444"}, {"db": "Human Phenotype Ontology", "id": "HP:0012189"}]}], "symbols": [{"value": {"type": "Preferred", "value": "CHL"}, "xrefs": [{"db": "OMIM", "id": "236000", "type": "MIM"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0009348"}, {"db": "MedGen", "id": "C0019829"}, {"db": "Orphanet", "id": "391"}, {"db": "OMIM", "id": "236000", "type": "MIM"}, {"db": "Human Phenotype Ontology", "id": "HP:0012189", "type": "primary"}]}], "id": 81}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57800}, "record_status": "current", "title": "NM_173546.3(KLHDC8B):c.-158C>T AND Classic Hodgkin lymphoma", "clinvar_assertions": [{"id": 20441, "clinvar_submission_id": {"local_key": "613169.0001_HODGKIN LYMPHOMA", "submitter": "OMIM", "title": "KLHDC8B, 5-PRIME UTR, +28C-T_HODGKIN LYMPHOMA", "submitter_date": "2010-09-08"}, "clinvar_accession": {"acc": "SCV000020441", "version": 1, "type": "SCV", "date_updated": "2013-04-04", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2009-09-01"}], "external_ids": [{"db": "OMIM", "id": "613169.0001", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Salipante et al. (2009) analyzed the KLHDC8B gene in 52 probands from families with 2 or more individuals with classic Hodgkin lymphoma (236000) and identified a +28C-T transition at a highly conserved nucleotide in the 5-prime UTR that was present in probands from 3 (5.8%) of 52 families compared with 4 (1.3%) of 307 controls (odds ratio, 4.64; 95% confidence interval, 1.01-21.4). The variant segregated with disease, and individuals heterozygous for the T allele were found to produce lower levels of KLHDC8B than those homozygous for the more common C allele. Studies in transfected HeLA cells demonstrated an approximately 50% reduction in translation of mRNA with the T allele compared to the C allele."}, "citations": [{"ids": [{"source": "PubMed", "value": "19706467"}]}], "xrefs": [{"db": "OMIM", "id": "236000", "type": "MIM"}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "KLHDC8B, 5-PRIME UTR, +28C-T"}}], "attributes": [{"type": "NonHGVS", "value": "5-PRIME UTR, +28C-T"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "KLHDC8B"}}]}], "xrefs": [{"db": "OMIM", "id": "613169.0001", "type": "Allelic variant"}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000434", "version": 3, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2009-06-01"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided", "family_data": {"num_families": 1}}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a 19-year-old Spanish woman with urocanic aciduria, mental retardation, and ataxia (UROCD; 276880), Espinos et al. (2009) identified compound heterozygosity for a 1348C-T transition in exon 14 of the UROC1 gene, resulting in an arg450-to-cys (R450C) substitution at a highly conserved residue, and a 209T-C transition in exon 2 (613012.0002), resulting in a leu70to-pro (L70P) substitution in the N-terminal alpha helix. Both mutations were predicted to have a pathologic effect, and enzyme activity was not detectable in R450C urocanase extracts in a bacterial expression system. The unaffected father was heterozygous for R450C mutation, but DNA from the mother was unavailable for testing. Neither mutation was found in 200 ethnically matched control chromosomes."}, "citations": [{"ids": [{"source": "PubMed", "value": "19304569"}], "type": "general"}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000000407", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_144639.3(UROC1):c.1348C>T (p.Arg450Cys)"}}], "canonical_spdi": "NC_000003.12:126498140:G:A", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_144639.3:c.1348C>T"}, {"type": "HGVS, coding, RefSeq", "value": "NM_001165974.2:c.1528C>T"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_016286.1:g.24611C>T"}, {"type": "HGVS, genomic, top level", "value": "NC_000003.12:g.126498141G>A"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000003.11:g.126216984G>A"}, {"type": "HGVS, protein, RefSeq", "value": "NP_653240.1:p.Arg450Cys"}, {"type": "HGVS, protein, RefSeq", "value": "NP_001159446.1:p.Arg510Cys"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_001165974.2:c.1528C>T"}]}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_144639.3:c.1348C>T"}]}, {"type": "ProteinChange1LetterCode", "value": "R450C"}, {"type": "ProteinChange1LetterCode", "value": "R510C"}, {"type": "ProteinChange3LetterCode", "value": "ARG450CYS"}], "global_minor_allele_frequency": {"value": 0.0002, "source": "1000 Genomes Project", "minor_allele": "A"}, "sequence_location": [{"assembly": "GRCh38", "chr": "3", "accession": "NC_000003.12", "start": 126498141, "stop": 126498141, "display_start": 126498141, "display_stop": 126498141, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 126498141, "reference_allele_vcf": "G", "alternate_allele_vcf": "A"}, {"assembly": "GRCh37", "chr": "3", "accession": "NC_000003.11", "start": 126216984, "stop": 126216984, "display_start": 126216984, "display_stop": 126216984, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 126216984, "reference_allele_vcf": "G", "alternate_allele_vcf": "A"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "urocanate hydratase 1"}}], "symbols": [{"value": {"type": "Preferred", "value": "UROC1"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "3", "accession": "NC_000003.12", "start": 126481166, "stop": 126517773, "display_start": 126481166, "display_stop": 126517773, "strand": "-", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "3", "accession": "NC_000003.11", "start": 126200007, "stop": 126236615, "display_start": 126200007, "display_stop": 126236615, "strand": "-", "variant_length": 36609, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "131669"}, {"db": "OMIM", "id": "613012", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:26444"}]}], "xrefs": [{"db": "OMIM", "id": "613012.0001", "type": "Allelic variant"}, {"db": "dbSNP", "id": "137852795", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_144639.3(UROC1):c.1348C>T (p.Arg450Cys)"}}], "xrefs": [{"db": "ClinGen", "id": "CA114248"}], "id": 407}, "trait_set": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Urocanate hydratase deficiency"}, "xrefs": [{"db": "Genetic Alliance", "id": "Urocanate+hydratase+deficiency/9437"}, {"db": "SNOMED CT", "id": "60952007"}]}, {"value": {"type": "Alternate", "value": "Urocanase deficiency"}}, {"value": {"type": "Alternate", "value": "Urocanic aciduria"}, "xrefs": [{"db": "Human Phenotype Ontology", "id": "HP:0012237"}, {"db": "MONDO", "id": "MONDO:0010167"}]}], "symbols": [{"value": {"type": "Preferred", "value": "UROCD"}, "xrefs": [{"db": "OMIM", "id": "276880", "type": "MIM"}]}], "attributes": [{"value": {"type": "GARD id"}, "xrefs": [{"db": "Office of Rare Diseases", "id": "8539"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0010167"}, {"db": "MedGen", "id": "C0268514"}, {"db": "Orphanet", "id": "210128"}, {"db": "OMIM", "id": "276880", "type": "MIM"}, {"db": "Human Phenotype Ontology", "id": "HP:0012237", "type": "primary"}]}], "id": 111}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57937}, "record_status": "current", "title": "NM_144639.3(UROC1):c.1348C>T (p.Arg450Cys) AND Urocanate hydratase deficiency", "clinvar_assertions": [{"id": 20582, "clinvar_submission_id": {"local_key": "613012.0001_UROCANASE DEFICIENCY (1 family)", "submitter": "OMIM", "title": "UROC1, ARG450CYS_UROCANASE DEFICIENCY (1 family)", "submitter_date": "2015-05-12"}, "clinvar_accession": {"acc": "SCV000020582", "version": 2, "type": "SCV", "date_updated": "2015-05-18", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2009-06-01"}], "external_ids": [{"db": "OMIM", "id": "613012.0001", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided", "family_data": {"num_families": 1}}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a 19-year-old Spanish woman with urocanic aciduria, mental retardation, and ataxia (UROCD; 276880), Espinos et al. (2009) identified compound heterozygosity for a 1348C-T transition in exon 14 of the UROC1 gene, resulting in an arg450-to-cys (R450C) substitution at a highly conserved residue, and a 209T-C transition in exon 2 (613012.0002), resulting in a leu70to-pro (L70P) substitution in the N-terminal alpha helix. Both mutations were predicted to have a pathologic effect, and enzyme activity was not detectable in R450C urocanase extracts in a bacterial expression system. The unaffected father was heterozygous for R450C mutation, but DNA from the mother was unavailable for testing. Neither mutation was found in 200 ethnically matched control chromosomes."}, "citations": [{"ids": [{"source": "PubMed", "value": "19304569"}]}], "xrefs": [{"db": "OMIM", "id": "276880", "type": "MIM"}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "UROC1, ARG450CYS"}}], "attributes": [{"type": "NonHGVS", "value": "ARG450CYS"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "UROC1"}}]}], "xrefs": [{"db": "OMIM", "id": "613012.0001", "type": "Allelic variant"}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000467", "version": 1, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "benign", "date_last_evaluated": "2010-12-30"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Parsons et al. (1997) demonstrated that the Lu(a)/(b) polymorphism (111200) results from a 252G-A transition in exon 3 of the BCAM gene, resulting in a his77-to-arg (H77R) substitution in immunoglobulin domain-1. The Lutheran glycoprotein of Lu(b) immunospecificity has arginine at position 77."}, "citations": [{"ids": [{"source": "PubMed", "value": "9166867"}], "type": "general"}]}, {"attribute": {"type": "Description", "value": "El Nemer et al. (1997) reported the Lu(a)/Lu(b) polymorphism as a 229A-G nucleotide change, resulting in a H77R substitution for the Lu(b) allele. When expressed in Chinese hamster ovary (CHO) cells, Lu cDNAs carrying 229A or 229G produced cell surface proteins that reacted with anti-Lu(a) or anti-Lu(b) antibodies, respectively, showing that these nucleotides specified the 2 major alleles of the Lutheran blood group locus."}, "citations": [{"ids": [{"source": "PubMed", "value": "9192786"}], "type": "general"}]}, {"attribute": {"type": "Description", "value": "Karamatic Crew et al. (2007) noted that Lu(a)/(b) is also referred to as Lu(1)/(2)."}, "citations": [{"ids": [{"source": "PubMed", "value": "17319831"}], "type": "general"}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000000438", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_005581.4(BCAM):c.230G>A (p.Arg77His)"}}, {"value": {"type": "Alternate", "value": "H77R"}, "xrefs": [{"db": "OMIM", "id": "612773.0001", "type": "Allelic variant"}]}], "canonical_spdi": "NC_000019.10:44812187:G:A", "attributes": [{"type": "HGVS, coding, LRG", "value": "LRG_798t2:c.230G>A"}, {"type": "HGVS, coding, RefSeq", "value": "NM_001013257.2:c.230G>A"}, {"type": "HGVS, coding, RefSeq", "value": "NM_005581.5:c.230G>A"}, {"type": "HGVS, genomic, LRG", "value": "LRG_798:g.8108G>A"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_007480.1:g.8108G>A"}, {"type": "HGVS, genomic, top level", "value": "NC_000019.10:g.44812188G>A"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000019.9:g.45315445G>A"}, {"type": "HGVS, protein"}, {"type": "HGVS, protein", "value": "LRG_798p2:p.Arg77His"}, {"type": "HGVS, protein", "value": "P50895:p.Arg77His"}, {"type": "HGVS, protein, RefSeq", "value": "NP_001013275.1:p.Arg77His"}, {"type": "HGVS, protein, RefSeq", "value": "NP_005572.2:p.Arg77His"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_001013257.2:c.230G>A"}]}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_005581.5:c.230G>A"}]}, {"type": "ProteinChange1LetterCode", "value": "R77H"}, {"type": "ProteinChange3LetterCode", "value": "HIS77ARG"}], "global_minor_allele_frequency": {"value": 0.01677, "source": "1000 Genomes Project", "minor_allele": "A"}, "sequence_location": [{"assembly": "GRCh38", "chr": "19", "accession": "NC_000019.10", "start": 44812188, "stop": 44812188, "display_start": 44812188, "display_stop": 44812188, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 44812188, "reference_allele_vcf": "G", "alternate_allele_vcf": "A"}, {"assembly": "GRCh37", "chr": "19", "accession": "NC_000019.9", "start": 45315445, "stop": 45315445, "display_start": 45315445, "display_stop": 45315445, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 45315445, "reference_allele_vcf": "G", "alternate_allele_vcf": "A"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "basal cell adhesion molecule (Lutheran blood group)"}}], "symbols": [{"value": {"type": "Preferred", "value": "BCAM"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "19", "accession": "NC_000019.10", "start": 44809059, "stop": 44821421, "display_start": 44809059, "display_stop": 44821421, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "19", "accession": "NC_000019.9", "start": 45312315, "stop": 45324677, "display_start": 45312315, "display_stop": 45324677, "strand": "+", "variant_length": 12363, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "4059"}, {"db": "OMIM", "id": "612773", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:6722"}]}], "xrefs": [{"db": "UniProtKB", "id": "P50895#VAR_021348"}, {"db": "OMIM", "id": "612773.0001", "type": "Allelic variant"}, {"db": "dbSNP", "id": "28399653", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_005581.4(BCAM):c.230G>A (p.Arg77His)"}}], "xrefs": [{"db": "ClinGen", "id": "CA114284"}], "id": 438}, "trait_set": {"type": "Disease", "traits": [{"type": "BloodGroup", "names": [{"value": {"type": "Preferred", "value": "LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b)"}, "xrefs": [{"db": "OMIM", "id": "612773.0001", "type": "Allelic variant"}]}]}], "id": 123}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57970}, "record_status": "current", "title": "NM_005581.4(BCAM):c.230G>A (p.Arg77His) AND LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b)", "clinvar_assertions": [{"id": 20616, "clinvar_submission_id": {"local_key": "612773.0001_LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b)", "submitter": "OMIM", "title": "BCAM, HIS77ARG_LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b)", "submitter_date": "2009-06-25"}, "clinvar_accession": {"acc": "SCV000020616", "version": 1, "type": "SCV", "date_updated": "2013-04-04", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["benign"], "date_last_evaluated": "2010-12-30"}], "external_ids": [{"db": "OMIM", "id": "612773.0001", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Parsons et al. (1997) demonstrated that the Lu(a)/(b) polymorphism (111200) results from a 252G-A transition in exon 3 of the BCAM gene, resulting in a his77-to-arg (H77R) substitution in immunoglobulin domain-1. The Lutheran glycoprotein of Lu(b) immunospecificity has arginine at position 77."}, "citations": [{"ids": [{"source": "PubMed", "value": "9166867"}]}], "xrefs": [{"db": "OMIM", "id": "111200", "type": "MIM"}]}, {"attribute": {"type": "Description", "value": "El Nemer et al. (1997) reported the Lu(a)/Lu(b) polymorphism as a 229A-G nucleotide change, resulting in a H77R substitution for the Lu(b) allele. When expressed in Chinese hamster ovary (CHO) cells, Lu cDNAs carrying 229A or 229G produced cell surface proteins that reacted with anti-Lu(a) or anti-Lu(b) antibodies, respectively, showing that these nucleotides specified the 2 major alleles of the Lutheran blood group locus."}, "citations": [{"ids": [{"source": "PubMed", "value": "9192786"}]}]}, {"attribute": {"type": "Description", "value": "Karamatic Crew et al. (2007) noted that Lu(a)/(b) is also referred to as Lu(1)/(2)."}, "citations": [{"ids": [{"source": "PubMed", "value": "17319831"}]}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "BCAM, HIS77ARG"}}], "attributes": [{"type": "NonHGVS", "value": "HIS77ARG"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "BCAM"}}]}], "xrefs": [{"db": "OMIM", "id": "612773.0001", "type": "Allelic variant"}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000471", "version": 3, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2007-03-01"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a healthy Japanese man with the Lutheran null blood group phenotype (247420), Mallinson et al. (1997) identified a homozygous 733C-A transversion in exon 6 of the BCAM gene, resulting in a cys237-to-ter (C237X) substitution in the extracellular domain. He was identified through blood donation and had no phenotypic manifestations. His parents and brother were heterozygous for the mutation. Karamatic Crew et al. (2007) stated that the C237X substitution resulted from a 711C-A transversion based on numbering from the translation initiation ATG codon."}, "citations": [{"ids": [{"source": "PubMed", "value": "17319831"}], "type": "general"}, {"type": "general", "citation_text": "Mallinson, G., Green, C. A., Okubo, Y., Daniels, G. L. The molecular background of recessive Lu(a-b-) phenotype in a Japanese family. Transfusion Med. 7 (Suppl. 1): 18-only, 1997."}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000000442", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_005581.5(BCAM):c.711C>A (p.Cys237Ter)"}}], "canonical_spdi": "NC_000019.10:44813546:C:A", "attributes": [{"type": "HGVS, coding, LRG", "value": "LRG_798t2:c.711C>A"}, {"type": "HGVS, coding, RefSeq", "value": "NM_001013257.2:c.711C>A"}, {"type": "HGVS, coding, RefSeq", "value": "NM_005581.5:c.711C>A"}, {"type": "HGVS, genomic, LRG", "value": "LRG_798:g.9467C>A"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_007480.1:g.9467C>A"}, {"type": "HGVS, genomic, top level", "value": "NC_000019.10:g.44813547C>A"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000019.9:g.45316804C>A"}, {"type": "HGVS, protein"}, {"type": "HGVS, protein", "value": "LRG_798p2:p.Cys237Ter"}, {"type": "HGVS, protein, RefSeq", "value": "NP_001013275.1:p.Cys237Ter"}, {"type": "HGVS, protein, RefSeq", "value": "NP_005572.2:p.Cys237Ter"}, {"type": "MolecularConsequence", "value": "nonsense", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001587"}, {"db": "RefSeq", "id": "NM_001013257.2:c.711C>A"}]}, {"type": "MolecularConsequence", "value": "nonsense", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001587"}, {"db": "RefSeq", "id": "NM_005581.5:c.711C>A"}]}, {"type": "ProteinChange1LetterCode", "value": "C237*"}, {"type": "ProteinChange3LetterCode", "value": "CYS237TER"}], "global_minor_allele_frequency": {"value": 0.10004, "source": "1000 Genomes Project", "minor_allele": "T"}, "sequence_location": [{"assembly": "GRCh38", "chr": "19", "accession": "NC_000019.10", "start": 44813547, "stop": 44813547, "display_start": 44813547, "display_stop": 44813547, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 44813547, "reference_allele_vcf": "C", "alternate_allele_vcf": "A"}, {"assembly": "GRCh37", "chr": "19", "accession": "NC_000019.9", "start": 45316804, "stop": 45316804, "display_start": 45316804, "display_stop": 45316804, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 45316804, "reference_allele_vcf": "C", "alternate_allele_vcf": "A"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "basal cell adhesion molecule (Lutheran blood group)"}}], "symbols": [{"value": {"type": "Preferred", "value": "BCAM"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "19", "accession": "NC_000019.10", "start": 44809059, "stop": 44821421, "display_start": 44809059, "display_stop": 44821421, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "19", "accession": "NC_000019.9", "start": 45312315, "stop": 45324677, "display_start": 45312315, "display_stop": 45324677, "strand": "+", "variant_length": 12363, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "4059"}, {"db": "OMIM", "id": "612773", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:6722"}]}], "xrefs": [{"db": "OMIM", "id": "612773.0005", "type": "Allelic variant"}, {"db": "dbSNP", "id": "3810141", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_005581.5(BCAM):c.711C>A (p.Cys237Ter)"}}], "xrefs": [{"db": "ClinGen", "id": "CA114290"}], "id": 442}, "trait_set": {"type": "Disease", "traits": [{"type": "BloodGroup", "names": [{"value": {"type": "Preferred", "value": "BLOOD GROUP--LUTHERAN NULL"}, "xrefs": [{"db": "OMIM", "id": "612773.0003", "type": "Allelic variant"}, {"db": "OMIM", "id": "612773.0004", "type": "Allelic variant"}, {"db": "OMIM", "id": "612773.0005", "type": "Allelic variant"}, {"db": "OMIM", "id": "612773.0006", "type": "Allelic variant"}]}], "xrefs": [{"db": "MedGen", "id": "C4017284"}]}], "id": 125}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57974}, "record_status": "current", "title": "NM_005581.5(BCAM):c.711C>A (p.Cys237Ter) AND BLOOD GROUP--LUTHERAN NULL", "clinvar_assertions": [{"id": 20620, "clinvar_submission_id": {"local_key": "612773.0005_BLOOD GROUP--LUTHERAN NULL", "submitter": "OMIM", "title": "BCAM, CYS237TER_BLOOD GROUP--LUTHERAN NULL", "submitter_date": "2018-02-05"}, "clinvar_accession": {"acc": "SCV000020620", "version": 2, "type": "SCV", "date_updated": "2018-02-08", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2007-03-01"}], "external_ids": [{"db": "OMIM", "id": "612773.0005", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a healthy Japanese man with the Lutheran null blood group phenotype (247420), Mallinson et al. (1997) identified a homozygous 733C-A transversion in exon 6 of the BCAM gene, resulting in a cys237-to-ter (C237X) substitution in the extracellular domain. He was identified through blood donation and had no phenotypic manifestations. His parents and brother were heterozygous for the mutation. Karamatic Crew et al. (2007) stated that the C237X substitution resulted from a 711C-A transversion based on numbering from the translation initiation ATG codon."}, "citations": [{"citation_text": "Mallinson, G., Green, C. A., Okubo, Y., Daniels, G. L. The molecular background of recessive Lu(a-b-) phenotype in a Japanese family. Transfusion Med. 7 (Suppl. 1): 18-only, 1997."}, {"ids": [{"source": "PubMed", "value": "17319831"}]}], "xrefs": [{"db": "OMIM", "id": "247420", "type": "MIM"}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "BCAM, CYS237TER"}}], "attributes": [{"type": "NonHGVS", "value": "CYS237TER"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "BCAM"}}]}], "xrefs": [{"db": "OMIM", "id": "612773.0005", "type": "Allelic variant"}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000722", "version": 2, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "1993-08-01"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a Belgian patient with fucosidosis (230000), Seo et al. (1993) found homozygosity for a C-to-A transversion in exon 3 converting codon 211 from tyrosine to stop (Y211X)."}, "citations": [{"ids": [{"source": "PubMed", "value": "8401503"}], "type": "general"}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000000687", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_000147.5(FUCA1):c.648C>A (p.Tyr216Ter)"}}, {"value": {"type": "Alternate", "value": "FUCA1, TYR211TER"}, "xrefs": [{"db": "OMIM", "id": "612280.0007", "type": "Allelic variant"}]}], "canonical_spdi": "NC_000001.11:23863147:G:T", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_000147.5:c.648C>A"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_013346.1:g.10222C>A"}, {"type": "HGVS, genomic, top level", "value": "NC_000001.11:g.23863148G>T"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000001.10:g.24189638G>T"}, {"type": "HGVS, protein, RefSeq", "value": "NP_000138.2:p.Tyr216Ter"}, {"type": "MolecularConsequence", "value": "nonsense", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001587"}, {"db": "RefSeq", "id": "NM_000147.5:c.648C>A"}]}, {"type": "ProteinChange1LetterCode", "value": "Y216*"}], "global_minor_allele_frequency": {"value": 0.0008, "source": "1000 Genomes Project", "minor_allele": "A"}, "sequence_location": [{"assembly": "GRCh38", "chr": "1", "accession": "NC_000001.11", "start": 23863148, "stop": 23863148, "display_start": 23863148, "display_stop": 23863148, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 23863148, "reference_allele_vcf": "G", "alternate_allele_vcf": "T"}, {"assembly": "GRCh37", "chr": "1", "accession": "NC_000001.10", "start": 24189638, "stop": 24189638, "display_start": 24189638, "display_stop": 24189638, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 24189638, "reference_allele_vcf": "G", "alternate_allele_vcf": "T"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "alpha-L-fucosidase 1"}}], "symbols": [{"value": {"type": "Preferred", "value": "FUCA1"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "1", "accession": "NC_000001.11", "start": 23845077, "stop": 23868290, "display_start": 23845077, "display_stop": 23868290, "strand": "-", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "1", "accession": "NC_000001.10", "start": 24171566, "stop": 24194858, "display_start": 24171566, "display_stop": 24194858, "strand": "-", "variant_length": 23293, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "2517"}, {"db": "OMIM", "id": "612280", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:4006"}]}], "xrefs": [{"db": "OMIM", "id": "612280.0007", "type": "Allelic variant"}, {"db": "dbSNP", "id": "80358198", "type": "rs"}], "comments": [{"text": "NCBI staff reviewed the sequence information reported in PubMed 8401503 to determine the location of this allele on current reference sequence (Y216*).", "type": "public", "datasource": "NCBI curation"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_000147.5(FUCA1):c.648C>A (p.Tyr216Ter)"}}], "xrefs": [{"db": "ClinGen", "id": "CA114442"}], "id": 687}, "trait_set": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Fucosidosis"}, "xrefs": [{"db": "GeneTests", "id": "3120"}, {"db": "Genetic Alliance", "id": "Fucosidosis/2958"}, {"db": "MONDO", "id": "MONDO:0009254"}, {"db": "SNOMED CT", "id": "64716005"}]}, {"value": {"type": "Alternate", "value": "Alpha-l-fucosidase deficiency"}}, {"value": {"type": "Alternate", "value": "Lysosomal storage disease caused by defective alpha-L-fucosidase with accumulation of fucose in the tissues"}}], "attributes": [{"value": {"type": "GARD id"}, "xrefs": [{"db": "Office of Rare Diseases", "id": "6473"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0009254"}, {"db": "MedGen", "id": "C0016788"}, {"db": "Orphanet", "id": "349"}, {"db": "OMIM", "id": "230000", "type": "MIM"}]}], "id": 172}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 58225}, "record_status": "current", "title": "NM_000147.5(FUCA1):c.648C>A (p.Tyr216Ter) AND Fucosidosis", "clinvar_assertions": [{"id": 20872, "clinvar_submission_id": {"local_key": "612280.0007_FUCOSIDOSIS", "submitter": "OMIM", "title": "FUCA1, TYR211TER_FUCOSIDOSIS", "submitter_date": "2011-04-21"}, "clinvar_accession": {"acc": "SCV000020872", "version": 1, "type": "SCV", "date_updated": "2013-04-04", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "1993-08-01"}], "external_ids": [{"db": "OMIM", "id": "612280.0007", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a Belgian patient with fucosidosis (230000), Seo et al. (1993) found homozygosity for a C-to-A transversion in exon 3 converting codon 211 from tyrosine to stop (Y211X)."}, "citations": [{"ids": [{"source": "PubMed", "value": "8401503"}]}], "xrefs": [{"db": "OMIM", "id": "230000", "type": "MIM"}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "FUCA1, TYR211TER"}}], "attributes": [{"type": "NonHGVS", "value": "TYR211TER"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "FUCA1"}}]}], "xrefs": [{"db": "OMIM", "id": "612280.0007", "type": "Allelic variant"}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000759", "version": 1, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "drug response", "date_last_evaluated": "2012-10-28"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "This mutation, caused by a 341T-C transition in the NAT2 gene that results in an ile114-to-thr (I114T) substitution, was identified in a liver with slow acetylation activity (243400) by Vatsis et al. (1991). This allele characterizes the NAT2*5B haplotype (Magalon et al., 2008)."}, "citations": [{"ids": [{"source": "PubMed", "value": "18043717"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "2068113"}], "type": "general"}]}, {"attribute": {"type": "Description", "value": "Patin et al. (2006) applied the long-range haplotype (LIH) test to define linkage disequilibrium in the region of chromosome 8 containing the NAT1 and NAT2 genes and the pseudogene NATP. In studies of 13 different populations with distinct ethnic backgrounds and demographic pasts, the LRH test identified a particular NAT2 haplotype (NAT2*5B) under recent positive selection in western/central Eurasians. This haplotype harbors the mutation 341T-C and encodes the 'slowest-acetylator' NAT2 enzyme, suggesting a general selective advantage for the slow-acetylator phenotype. Interestingly, the NAT2*5B haplotype, which seems to have conferred a selective advantage during the past 6,500 years, exhibits today the strongest association with susceptibility to bladder cancer and adverse drug reactions (Hein et al., 2000; Hein, 2002). Thus, the patterns observed for NAT2 illustrate how geographically and temporally fluctuating xenobiotic environments may have influenced not only our genome diversity but also our present day susceptibility to disease."}, "citations": [{"ids": [{"source": "PubMed", "value": "10667461"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "12351146"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "16416399"}], "type": "general"}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000000723", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_000015.2(NAT2):c.341T>C (p.Ile114Thr)"}}], "canonical_spdi": "NC_000008.11:18400343:T:C", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_000015.3:c.341T>C"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_012246.1:g.14100T>C"}, {"type": "HGVS, genomic, top level", "value": "NC_000008.11:g.18400344T>C"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000008.10:g.18257854T>C"}, {"type": "HGVS, protein, RefSeq", "value": "NP_000006.2:p.Ile114Thr"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_000015.3:c.341T>C"}]}, {"type": "ProteinChange1LetterCode", "value": "I114T"}, {"type": "ProteinChange3LetterCode", "value": "ILE114THR"}], "global_minor_allele_frequency": {"value": 0.29273, "source": "1000 Genomes Project", "minor_allele": "C"}, "sequence_location": [{"assembly": "GRCh38", "chr": "8", "accession": "NC_000008.11", "start": 18400344, "stop": 18400344, "display_start": 18400344, "display_stop": 18400344, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 18400344, "reference_allele_vcf": "T", "alternate_allele_vcf": "C"}, {"assembly": "GRCh37", "chr": "8", "accession": "NC_000008.10", "start": 18257854, "stop": 18257854, "display_start": 18257854, "display_stop": 18257854, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 18257854, "reference_allele_vcf": "T", "alternate_allele_vcf": "C"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "N-acetyltransferase 2"}}], "symbols": [{"value": {"type": "Preferred", "value": "NAT2"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "8", "accession": "NC_000008.11", "start": 18386301, "stop": 18401218, "display_start": 18386301, "display_stop": 18401218, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "8", "accession": "NC_000008.10", "start": 18248754, "stop": 18258722, "display_start": 18248754, "display_stop": 18258722, "strand": "+", "variant_length": 9969, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "10"}, {"db": "OMIM", "id": "612182", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:7646"}]}], "xrefs": [{"db": "OMIM", "id": "612182.0002", "type": "Allelic variant"}, {"db": "dbSNP", "id": "1801280", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_000015.2(NAT2):c.341T>C (p.Ile114Thr)"}}], "xrefs": [{"db": "ClinGen", "id": "CA114449"}], "id": 723}, "trait_set": {"type": "Disease", "traits": [{"type": "DrugResponse", "names": [{"value": {"type": "Preferred", "value": "Slow acetylator due to N-acetyltransferase enzyme variant"}, "xrefs": [{"db": "Genetic Alliance", "id": "Acetylation%2C+slow/7622"}, {"db": "SNOMED CT", "id": "425079005"}]}, {"value": {"type": "Alternate", "value": "INH INACTIVATION, SLOW"}, "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "ISONIAZID INACTIVATION, SLOW"}, "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "SLOW ACETYLATOR PHENOTYPE"}, "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "Acetylation, slow"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0009472"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0009472"}, {"db": "MedGen", "id": "C0878587"}, {"db": "OMIM", "id": "243400", "type": "MIM"}]}], "id": 178}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 58262}, "record_status": "current", "title": "NM_000015.2(NAT2):c.341T>C (p.Ile114Thr) AND Slow acetylator due to N-acetyltransferase enzyme variant", "clinvar_assertions": [{"id": 20909, "clinvar_submission_id": {"local_key": "612182.0002_ACETYLATION, SLOW", "submitter": "OMIM", "title": "NAT2, ILE114THR_ACETYLATION, SLOW", "submitter_date": "2010-02-16"}, "clinvar_accession": {"acc": "SCV000020909", "version": 1, "type": "SCV", "date_updated": "2013-04-04", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["drug response"], "date_last_evaluated": "2012-10-28"}], "external_ids": [{"db": "OMIM", "id": "612182.0002", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "This mutation, caused by a 341T-C transition in the NAT2 gene that results in an ile114-to-thr (I114T) substitution, was identified in a liver with slow acetylation activity (243400) by Vatsis et al. (1991). This allele characterizes the NAT2*5B haplotype (Magalon et al., 2008)."}, "citations": [{"ids": [{"source": "PubMed", "value": "2068113"}]}, {"ids": [{"source": "PubMed", "value": "18043717"}]}], "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"attribute": {"type": "Description", "value": "Patin et al. (2006) applied the long-range haplotype (LIH) test to define linkage disequilibrium in the region of chromosome 8 containing the NAT1 and NAT2 genes and the pseudogene NATP. In studies of 13 different populations with distinct ethnic backgrounds and demographic pasts, the LRH test identified a particular NAT2 haplotype (NAT2*5B) under recent positive selection in western/central Eurasians. This haplotype harbors the mutation 341T-C and encodes the 'slowest-acetylator' NAT2 enzyme, suggesting a general selective advantage for the slow-acetylator phenotype. Interestingly, the NAT2*5B haplotype, which seems to have conferred a selective advantage during the past 6,500 years, exhibits today the strongest association with susceptibility to bladder cancer and adverse drug reactions (Hein et al., 2000; Hein, 2002). Thus, the patterns observed for NAT2 illustrate how geographically and temporally fluctuating xenobiotic environments may have influenced not only our genome diversity but also our present day susceptibility to disease."}, "citations": [{"ids": [{"source": "PubMed", "value": "16416399"}]}, {"ids": [{"source": "PubMed", "value": "10667461"}]}, {"ids": [{"source": "PubMed", "value": "12351146"}]}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "NAT2, ILE114THR"}}], "attributes": [{"type": "NonHGVS", "value": "ILE114THR"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "NAT2"}}]}], "xrefs": [{"db": "OMIM", "id": "612182.0002", "type": "Allelic variant"}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000761", "version": 1, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "drug response", "date_last_evaluated": "2012-10-28"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 2 human livers, Ohsako and Deguchi (1990) identified a slow acetylator (243400) phenotype resulting from an 857G-A transition in the NAT2 gene, which causes a gly286-to-glu (G286E) substitution. Northern and Western blot analysis of transfected CHO cells revealed clearly visible mRNA and protein in cells transfected with the fast variant, but little in cells transfected with the slow variant, suggesting the difference in activity may be due to difference in the amount of enzyme. This allele characterizes the NAT2*7B haplotype (Magalon et al., 2008)."}, "citations": [{"ids": [{"source": "PubMed", "value": "18043717"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "1968463"}], "type": "general"}]}, {"attribute": {"type": "Description", "value": "Lin et al. (1993) provided evidence that this mutation is Asiatic; it constituted about a third of slow acetylator alleles among Hong Kong Chinese and Koreans but less than 5% of slow acetylator alleles in whites. The mutation is also referred to as 857A. The mutation also made up 32% of the slow acetylator alleles in the Hispanic babies born at a Los Angeles hospital. Thus, the mutation may reflect the Bering Strait migration of Asiatic peoples into the New World."}, "citations": [{"ids": [{"source": "PubMed", "value": "8460648"}], "type": "general"}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000000725", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_000015.2(NAT2):c.857G>A (p.Gly286Glu)"}}], "canonical_spdi": "NC_000008.11:18400859:G:A", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_000015.3:c.857G>A"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_012246.1:g.14616G>A"}, {"type": "HGVS, genomic, top level", "value": "NC_000008.11:g.18400860G>A"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000008.10:g.18258370G>A"}, {"type": "HGVS, protein, RefSeq", "value": "NP_000006.2:p.Gly286Glu"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_000015.3:c.857G>A"}]}, {"type": "ProteinChange1LetterCode", "value": "G286E"}, {"type": "ProteinChange3LetterCode", "value": "GLY286GLU"}], "global_minor_allele_frequency": {"value": 0.07728, "source": "1000 Genomes Project", "minor_allele": "A"}, "sequence_location": [{"assembly": "GRCh38", "chr": "8", "accession": "NC_000008.11", "start": 18400860, "stop": 18400860, "display_start": 18400860, "display_stop": 18400860, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 18400860, "reference_allele_vcf": "G", "alternate_allele_vcf": "A"}, {"assembly": "GRCh37", "chr": "8", "accession": "NC_000008.10", "start": 18258370, "stop": 18258370, "display_start": 18258370, "display_stop": 18258370, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 18258370, "reference_allele_vcf": "G", "alternate_allele_vcf": "A"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "N-acetyltransferase 2"}}], "symbols": [{"value": {"type": "Preferred", "value": "NAT2"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "8", "accession": "NC_000008.11", "start": 18386301, "stop": 18401218, "display_start": 18386301, "display_stop": 18401218, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "8", "accession": "NC_000008.10", "start": 18248754, "stop": 18258722, "display_start": 18248754, "display_stop": 18258722, "strand": "+", "variant_length": 9969, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "10"}, {"db": "OMIM", "id": "612182", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:7646"}]}], "xrefs": [{"db": "OMIM", "id": "612182.0004", "type": "Allelic variant"}, {"db": "dbSNP", "id": "1799931", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_000015.2(NAT2):c.857G>A (p.Gly286Glu)"}}], "xrefs": [{"db": "ClinGen", "id": "CA114453"}], "id": 725}, "trait_set": {"type": "Disease", "traits": [{"type": "DrugResponse", "names": [{"value": {"type": "Preferred", "value": "Slow acetylator due to N-acetyltransferase enzyme variant"}, "xrefs": [{"db": "Genetic Alliance", "id": "Acetylation%2C+slow/7622"}, {"db": "SNOMED CT", "id": "425079005"}]}, {"value": {"type": "Alternate", "value": "INH INACTIVATION, SLOW"}, "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "ISONIAZID INACTIVATION, SLOW"}, "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "SLOW ACETYLATOR PHENOTYPE"}, "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "Acetylation, slow"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0009472"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0009472"}, {"db": "MedGen", "id": "C0878587"}, {"db": "OMIM", "id": "243400", "type": "MIM"}]}], "id": 178}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 58264}, "record_status": "current", "title": "NM_000015.2(NAT2):c.857G>A (p.Gly286Glu) AND Slow acetylator due to N-acetyltransferase enzyme variant", "clinvar_assertions": [{"id": 20911, "clinvar_submission_id": {"local_key": "612182.0004_ACETYLATION, SLOW", "submitter": "OMIM", "title": "NAT2, GLY286GLU_ACETYLATION, SLOW", "submitter_date": "2010-02-16"}, "clinvar_accession": {"acc": "SCV000020911", "version": 1, "type": "SCV", "date_updated": "2013-04-04", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["drug response"], "date_last_evaluated": "2012-10-28"}], "external_ids": [{"db": "OMIM", "id": "612182.0004", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 2 human livers, Ohsako and Deguchi (1990) identified a slow acetylator (243400) phenotype resulting from an 857G-A transition in the NAT2 gene, which causes a gly286-to-glu (G286E) substitution. Northern and Western blot analysis of transfected CHO cells revealed clearly visible mRNA and protein in cells transfected with the fast variant, but little in cells transfected with the slow variant, suggesting the difference in activity may be due to difference in the amount of enzyme. This allele characterizes the NAT2*7B haplotype (Magalon et al., 2008)."}, "citations": [{"ids": [{"source": "PubMed", "value": "1968463"}]}, {"ids": [{"source": "PubMed", "value": "18043717"}]}], "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"attribute": {"type": "Description", "value": "Lin et al. (1993) provided evidence that this mutation is Asiatic; it constituted about a third of slow acetylator alleles among Hong Kong Chinese and Koreans but less than 5% of slow acetylator alleles in whites. The mutation is also referred to as 857A. The mutation also made up 32% of the slow acetylator alleles in the Hispanic babies born at a Los Angeles hospital. Thus, the mutation may reflect the Bering Strait migration of Asiatic peoples into the New World."}, "citations": [{"ids": [{"source": "PubMed", "value": "8460648"}]}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "NAT2, GLY286GLU"}}], "attributes": [{"type": "NonHGVS", "value": "GLY286GLU"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "NAT2"}}]}], "xrefs": [{"db": "OMIM", "id": "612182.0004", "type": "Allelic variant"}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000762", "version": 1, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "drug response", "date_last_evaluated": "2012-10-28"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Bell et al. (1993) demonstrated a 191G-A nucleotide substitution as the basis of slow acetylation (243400) in African Americans. In a study of 117 unrelated Black Africans, Delomenie et al. (1996) confirmed the African origin of the mutation. No excess of the slow acetylator phenotype was found in the 2 Black-African populations studied, Dogons from Mali and Gabonese, implying no need for fitting NAT2 polymorphism-sensitive therapies to black Africans, compared to Caucasians."}, "citations": [{"ids": [{"source": "PubMed", "value": "8102597"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "9156695"}], "type": "general"}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000000726", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_000015.3(NAT2):c.191G>A (p.Arg64Gln)"}}], "canonical_spdi": "NC_000008.11:18400193:G:A", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_000015.3:c.191G>A"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_012246.1:g.13950G>A"}, {"type": "HGVS, genomic, top level", "value": "NC_000008.11:g.18400194G>A"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000008.10:g.18257704G>A"}, {"type": "HGVS, previous", "value": "NM_000015.2:c.191G>A"}, {"type": "HGVS, protein, RefSeq", "value": "NP_000006.2:p.Arg64Gln"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_000015.3:c.191G>A"}]}, {"type": "nucleotide change", "value": "191G-A"}, {"type": "ProteinChange1LetterCode", "value": "R64Q"}], "global_minor_allele_frequency": {"value": 0.02776, "source": "1000 Genomes Project", "minor_allele": "A"}, "sequence_location": [{"assembly": "GRCh38", "chr": "8", "accession": "NC_000008.11", "start": 18400194, "stop": 18400194, "display_start": 18400194, "display_stop": 18400194, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 18400194, "reference_allele_vcf": "G", "alternate_allele_vcf": "A"}, {"assembly": "GRCh37", "chr": "8", "accession": "NC_000008.10", "start": 18257704, "stop": 18257704, "display_start": 18257704, "display_stop": 18257704, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 18257704, "reference_allele_vcf": "G", "alternate_allele_vcf": "A"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "N-acetyltransferase 2"}}], "symbols": [{"value": {"type": "Preferred", "value": "NAT2"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "8", "accession": "NC_000008.11", "start": 18386301, "stop": 18401218, "display_start": 18386301, "display_stop": 18401218, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "8", "accession": "NC_000008.10", "start": 18248754, "stop": 18258722, "display_start": 18248754, "display_stop": 18258722, "strand": "+", "variant_length": 9969, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "10"}, {"db": "OMIM", "id": "612182", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:7646"}]}], "xrefs": [{"db": "OMIM", "id": "612182.0005", "type": "Allelic variant"}, {"db": "dbSNP", "id": "1801279", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_000015.3(NAT2):c.191G>A (p.Arg64Gln)"}}], "xrefs": [{"db": "ClinGen", "id": "CA114455"}], "id": 726}, "trait_set": {"type": "Disease", "traits": [{"type": "DrugResponse", "names": [{"value": {"type": "Preferred", "value": "Slow acetylator due to N-acetyltransferase enzyme variant"}, "xrefs": [{"db": "Genetic Alliance", "id": "Acetylation%2C+slow/7622"}, {"db": "SNOMED CT", "id": "425079005"}]}, {"value": {"type": "Alternate", "value": "INH INACTIVATION, SLOW"}, "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "ISONIAZID INACTIVATION, SLOW"}, "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "SLOW ACETYLATOR PHENOTYPE"}, "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "Acetylation, slow"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0009472"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0009472"}, {"db": "MedGen", "id": "C0878587"}, {"db": "OMIM", "id": "243400", "type": "MIM"}]}], "id": 178}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 58265}, "record_status": "current", "title": "NM_000015.3(NAT2):c.191G>A (p.Arg64Gln) AND Slow acetylator due to N-acetyltransferase enzyme variant", "clinvar_assertions": [{"id": 20912, "clinvar_submission_id": {"local_key": "612182.0005_ACETYLATION, SLOW", "submitter": "OMIM", "title": "NAT2, 191G-A_ACETYLATION, SLOW", "submitter_date": "2010-02-16"}, "clinvar_accession": {"acc": "SCV000020912", "version": 1, "type": "SCV", "date_updated": "2013-04-04", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["drug response"], "date_last_evaluated": "2012-10-28"}], "external_ids": [{"db": "OMIM", "id": "612182.0005", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Bell et al. (1993) demonstrated a 191G-A nucleotide substitution as the basis of slow acetylation (243400) in African Americans. In a study of 117 unrelated Black Africans, Delomenie et al. (1996) confirmed the African origin of the mutation. No excess of the slow acetylator phenotype was found in the 2 Black-African populations studied, Dogons from Mali and Gabonese, implying no need for fitting NAT2 polymorphism-sensitive therapies to black Africans, compared to Caucasians."}, "citations": [{"ids": [{"source": "PubMed", "value": "8102597"}]}, {"ids": [{"source": "PubMed", "value": "9156695"}]}], "xrefs": [{"db": "OMIM", "id": "243400", "type": "MIM"}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "NAT2, 191G-A"}}], "attributes": [{"type": "NonHGVS", "value": "191G-A"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "NAT2"}}]}], "xrefs": [{"db": "OMIM", "id": "612182.0005", "type": "Allelic variant"}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000763", "version": 2, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "association", "date_last_evaluated": "2015-05-18"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a genomewide association study for variants associated with human pigmentation characteristics (SHEP10; 612267) among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals, Sulem et al. (2008) found that an A-to-T transversion in the TPCN2 gene (rs35264875), resulting in a met484-to-leu amino acid change (M484L), was significantly associated with blond rather than brown hair (P = 3.6 x 10(-30)). The rs35264875T allele was found at a frequency of 22%."}, "citations": [{"ids": [{"source": "PubMed", "value": "18488028"}], "type": "general"}]}]}], "measure_set": {"type": "Variant", "acc": "VCV000000727", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_139075.4(TPCN2):c.1450A>T (p.Met484Leu)"}}], "canonical_spdi": "NC_000011.10:69078930:A:T", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_139075.4:c.1450A>T"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_016153.1:g.35050A>T"}, {"type": "HGVS, genomic, top level", "value": "NC_000011.10:g.69078931A>T"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000011.9:g.68846399A>T"}, {"type": "HGVS, protein", "value": "Q8NHX9:p.Met484Leu"}, {"type": "HGVS, protein, RefSeq", "value": "NP_620714.2:p.Met484Leu"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_139075.4:c.1450A>T"}]}, {"type": "ProteinChange1LetterCode", "value": "M484L"}, {"type": "ProteinChange3LetterCode", "value": "MET484LEU"}], "global_minor_allele_frequency": {"value": 0.09964, "source": "1000 Genomes Project", "minor_allele": "T"}, "sequence_location": [{"assembly": "GRCh38", "chr": "11", "accession": "NC_000011.10", "start": 69078931, "stop": 69078931, "display_start": 69078931, "display_stop": 69078931, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 69078931, "reference_allele_vcf": "A", "alternate_allele_vcf": "T"}, {"assembly": "GRCh37", "chr": "11", "accession": "NC_000011.9", "start": 68846399, "stop": 68846399, "display_start": 68846399, "display_stop": 68846399, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 68846399, "reference_allele_vcf": "A", "alternate_allele_vcf": "T"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "two pore segment channel 2"}}], "symbols": [{"value": {"type": "Preferred", "value": "TPCN2"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "11", "accession": "NC_000011.10", "start": 69048932, "stop": 69090597, "display_start": 69048932, "display_stop": 69090597, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "11", "accession": "NC_000011.9", "start": 68816349, "stop": 68858071, "display_start": 68816349, "display_stop": 68858071, "strand": "+", "variant_length": 41723, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "219931"}, {"db": "OMIM", "id": "612163", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:20820"}]}], "xrefs": [{"db": "UniProtKB", "id": "Q8NHX9#VAR_047956"}, {"db": "OMIM", "id": "612163.0001", "type": "Allelic variant"}, {"db": "dbSNP", "id": "35264875", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_139075.4(TPCN2):c.1450A>T (p.Met484Leu)"}}], "xrefs": [{"db": "ClinGen", "id": "CA114457"}], "id": 727}, "trait_set": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Skin/hair/eye pigmentation, variation in, 10"}, "xrefs": [{"db": "Genetic Alliance", "id": "Skin-hair-eye+pigmentation%2C+variation+in%2C+10/9305"}]}, {"value": {"type": "Alternate", "value": "SKIN/HAIR/EYE PIGMENTATION 10, BLOND/BROWN HAIR"}, "xrefs": [{"db": "OMIM", "id": "612267", "type": "MIM"}, {"db": "OMIM", "id": "612163.0001", "type": "Allelic variant"}, {"db": "OMIM", "id": "612163.0002", "type": "Allelic variant"}]}], "symbols": [{"value": {"type": "Preferred", "value": "SHEP10"}, "xrefs": [{"db": "OMIM", "id": "612267", "type": "MIM"}]}], "xrefs": [{"db": "MedGen", "id": "C2677088"}, {"db": "OMIM", "id": "612267", "type": "MIM"}]}], "id": 179}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 58266}, "record_status": "current", "title": "NM_139075.4(TPCN2):c.1450A>T (p.Met484Leu) AND Skin/hair/eye pigmentation, variation in, 10", "clinvar_assertions": [{"id": 20913, "clinvar_submission_id": {"local_key": "612163.0001_SKIN/HAIR/EYE PIGMENTATION 10, BLOND/BROWN HAIR", "submitter": "OMIM", "title": "TPCN2, MET484LEU _SKIN/HAIR/EYE PIGMENTATION 10, BLOND/BROWN HAIR", "submitter_date": "2012-05-18"}, "clinvar_accession": {"acc": "SCV000020913", "version": 1, "type": "SCV", "date_updated": "2013-04-04", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["association"], "date_last_evaluated": "2015-05-18"}], "external_ids": [{"db": "OMIM", "id": "612163.0001", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a genomewide association study for variants associated with human pigmentation characteristics (SHEP10; 612267) among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals, Sulem et al. (2008) found that an A-to-T transversion in the TPCN2 gene (rs35264875), resulting in a met484-to-leu amino acid change (M484L), was significantly associated with blond rather than brown hair (P = 3.6 x 10(-30)). The rs35264875T allele was found at a frequency of 22%."}, "citations": [{"ids": [{"source": "PubMed", "value": "18488028"}]}], "xrefs": [{"db": "OMIM", "id": "612267", "type": "MIM"}]}]}], "measure_set": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "TPCN2, MET484LEU"}}], "attributes": [{"type": "NonHGVS", "value": "MET484LEU"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "TPCN2"}}]}], "xrefs": [{"db": "OMIM", "id": "612163.0001", "type": "Allelic variant"}]}]}}]}
